A Single Ascending Dose Study in Healthy Participants and Multiple Ascending Dose Study of CNTO 7160 in Participants With Asthma and Participants With Atopic Dermatitis

NCT02345928 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

108

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma
Atopic Dermatitis
Healthy

Interventions

DRUG: Part 1: CNTO 7160
DRUG: Part 2 (Asthma): CNTO 7160
DRUG: Part 2 (Atopic Dermatitis): CNTO 7160
DRUG: Part 1 and Part 2: Placebo

Sponsor

Janssen Research & Development, LLC